A 65-year-old man with COPD (FEV1 45% predicted) has frequent exacerbations despite long-acting bronchodilator therapy. According to CTS COPD guidelines, which additional intervention has strong evidence to reduce future exacerbations and mortality in selected patients with chronic bronchitis phenotype?